Literature DB >> 14513370

Differential enhancement of collagen crosslink excretion in cases of osteosarcoma and chondrosarcoma.

Yahya Açil1, Ingo Springer, Peter Behrens, Klaus-Peter Ullrich, Juergen Hedderich, Juergen Bruns.   

Abstract

Hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) are markers of collagen absorption and LP is specific for collagen type I in bone. In the present study we evaluated the concentration of HP and LP in urine of patients with osteosarcoma ( n=20; age range 16-49 years) and chondrosarcoma ( n=15; age range 18-70 years). The values were compared with those obtained from 74 healthy controls (age range 16-83 years). The range and upper limit of normal values (HP(max) and LP(max)) were measured in our control group. High performance liquid chromatography (HPLC) was used to determine concentrations of HP and LP (nmol/mmol creatinine). The average urinary HP concentrations were significantly increased in patients with osteosarcoma ( p=0.001) and chondrosarcoma ( p<0.001), whereas HP remained within the normal range in approximately half of the patients. The average urinary LP concentrations were not increased in osteosarcoma and chondrosarcoma patients as compared with the control group. Further studies in a large group of patients are necessary to evaluate whether HP might be a valuable marker of prognosis, and if its urinary concentration can be correlated to tumour burden.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513370     DOI: 10.1007/s00432-003-0470-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  35 in total

1.  Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.

Authors:  F J Papatheofanis
Journal:  J Nucl Med       Date:  1997-08       Impact factor: 10.057

2.  Ehlers-Danlos syndrome type VI: cross-link pattern in tissue and urine sample as a diagnostic marker.

Authors:  Y Açil; U Vetter; R Brenner; P K Müller; J Brinckmann
Journal:  J Am Acad Dermatol       Date:  1995-09       Impact factor: 11.527

3.  [The biochemical markers of bone remodeling in cancer patients with skeletal involvement].

Authors:  N V Liubimova; I Iu Bronnikov; S P Robins; M F Trapeznikova; N E Kushlinskiĭ
Journal:  Vopr Onkol       Date:  2000

Review 4.  Biochemical markers and skeletal metastases.

Authors:  L M Demers; L Costa; A Lipton
Journal:  Cancer       Date:  2000-06-15       Impact factor: 6.860

Review 5.  Osteosarcoma: a multidisciplinary approach to diagnosis and treatment.

Authors:  James C Wittig; Jacob Bickels; Dennis Priebat; James Jelinek; Kristen Kellar-Graney; Barr Shmookler; Martin M Malawer
Journal:  Am Fam Physician       Date:  2002-03-15       Impact factor: 3.292

6.  The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease.

Authors:  M Pecherstorfer; I Zimmer-Roth; T Schilling; H W Woitge; H Schmidt; G Baumgartner; D Thiébaud; H Ludwig; M J Seibel
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

7.  Isolation of hydroxylysyl pyridinoline, a mature collagen crosslink from neonatal rat aorta smooth muscle cell cultures.

Authors:  P J Stone; J Bryan-Rhadfi; H A Shaw; C Franzblau
Journal:  Matrix       Date:  1992-11

8.  Bone turnover in malnourished children.

Authors:  F Branca; S P Robins; A Ferro-Luzzi; M H Golden
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

9.  Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases.

Authors:  J Walls; A Assiri; A Howell; E Rogers; W A Ratcliffe; R Eastell; N J Bundred
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

10.  Metabolic effects of pamidronate in patients with metastatic bone disease.

Authors:  J Vinholes; C Y Guo; O P Purohit; R Eastell; R E Coleman
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

View more
  1 in total

1.  The post-translational phenotype of collagen synthesized by SAOS-2 osteosarcoma cells.

Authors:  Russell J Fernandes; Michael A Harkey; Maryann Weis; Jennifer W Askew; David R Eyre
Journal:  Bone       Date:  2007-01-25       Impact factor: 4.398

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.